Actinium Pharmaceuticals (ATNM)
(Delayed Data from AMEX)
$1.80 USD
-0.08 (-4.26%)
Updated Sep 20, 2024 03:55 PM ET
After-Market: $1.80 0.00 (0.00%) 7:44 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.35 | 0.00% |
Earnings Summary
For their last quarter, Actinium Pharmaceuticals (ATNM) reported earnings of -$0.38 per share, beating the Zacks Consensus Estimate of $-0.48 per share. This reflects a positive earnings surprise of 20.83%. Look out for ATNM's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.35 per share, reflecting a year-over-year increase of 28.57%.
Earnings History
Price & Consensus
Zacks News for ATNM
Is Affimed (AFMD) Outperforming Other Medical Stocks This Year?
ATNM: What are Zacks experts saying now?
Zacks Private Portfolio Services